Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Public ClinicalTrials.gov record NCT00559702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Dose-Ranging Study to Evaluate the Pharmacokinetics and Initial Safety of Subcutaneous and Intramuscular Natalizumab in Subjects With Multiple Sclerosis
Study identification
- NCT ID
- NCT00559702
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 76 participants
Conditions and interventions
Interventions
- natalizumab Drug
- standard of care Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- Oct 31, 2011
- Completion
- Oct 31, 2011
- Last update posted
- Sep 8, 2014
2007 – 2011
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Scottsdale | Arizona | 85259 | — |
| Research Site | Berkeley | California | 94705 | — |
| Research Site | Centennial | Colorado | 80112 | — |
| Research Site | Maitland | Florida | 32751 | — |
| Research Site | Vero Beach | Florida | 32960 | — |
| Research Site | Peoria | Illinois | 61637 | — |
| Research Site | Farmington Hills | Michigan | 48334 | — |
| Research Site | Buffalo | New York | 14203 | — |
| Research Site | Dallas | Texas | 75214 | — |
| Research Site | Round Rock | Texas | 78681 | — |
| Research Site | Vienna | Virginia | 22182 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00559702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2014 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00559702 live on ClinicalTrials.gov.